Centers for Disease Control and Prevention: FDA filings under this applicant name
FDA lists 28 510(k) clearances under the applicant name “Centers for Disease Control and Prevention” (first 1981, latest 2026), plus 1 PMA and 4 De Novo decisions, across 13 product codes in 3 review panels. Median 510(k) review time under this name: 36 days. Since 2017 the median was 30 days, against 84 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 3 | 42 |
| 2014 | 3 | 22 |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 1 | 29 |
| 2018 | 1 | 136 |
| 2019 | 2 | 36 |
| 2020 | 1 | 25 |
| 2021 | 0 | — |
| 2022 | 3 | 2 |
| 2023 | 0 | — |
| 2024 | 1 | 29 |
| 2025 | 3 | 91 |
| 2026 | 3 | 30 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Centers for Disease Control and Prevention took a median 30 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 84 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| OZE | Influenza A And Influenza B Multiplex Nucleic Acid Assay | 10 | 10 |
| PBK | Non-Variola Orthopoxvirus Real-Time Pcr Primer And Probe Set | 5 | 4 |
| OQW | 2009 H1n1 Influenza Virus (Swine Origin), Nucleic Acid Or Antigen, Detection And Identification | 4 | 4 |
| LHL | Reagents, Antibody, Legionella, Direct & Indirect Fluorescent | 2 | 2 |
| NHT | Assay, Nucleic Acid Amplification, Bacillus Anthracis | 2 | 2 |
| NXD | Nucleic Acid Amplification, Novel Influenza A Virus, A/H5 (Asian Lineage) Rna | 2 | 1 |
| SGA | Biothreat Microbial Agent Nucleic Acid Detection Test | 2 | 2 |
| DHN | Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control | 1 | 1 |
| GMQ | Antigens, Nontreponemal, All | 1 | 1 |
| LTQ | Calibrator For Alpha-Fetoprotein In Mid-Pregnancy Maternal Serum | 1 | 0 |
Plus 3 more product codes.
Review panels
- Microbiology (30)
- Immunology (2)
- Clinical Toxicology (1)
Most recent Centers for Disease Control and Prevention 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K262368 | B. anthracis Real-time PCR Assay | NHT | 2026-10-07 | 89 |
| K263035 | CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel (includes Influenza A/B Typing Kit, Influenza A Subtyping Kit, Influenza A(H5) Subtyping Kit, and Influenza B Lineage Genotyping Kit) | OZE | 2026-09-30 | 30 |
| K260812 | Francisella tularensis Real-time PCR Assay | SGA | 2026-03-30 | 17 |
| K252072 | Francisella tularensis Real-time PCR assay | SGA | 2025-09-30 | 91 |
| K243274 | CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A SubTyping Kit (VER 4); Influenza B Genotyping Kit (VER 1.1 and 2); and Influenza A/H5 Subtyping Kit (VER 4) | OZE | 2025-07-11 | 268 |
| K243931 | CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A Subtyping Kit (VER 4); Influenza B Lineage Genotyping Kit (VER 1.1 and 2); and Influenza A/H5 Subtyping Kit (VER 4) | OZE | 2025-03-14 | 84 |
| K241110 | CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit (Ver4) | OZE | 2024-05-21 | 29 |
| K222558 | Non-variola Orthopoxvirus Real-time PCR Primer and Probe Set | PBK | 2022-08-30 | 6 |
| K221834 | Non-variola Orthopoxvirus Real-time PCR Primer and Probe Set | PBK | 2022-06-24 | 1 |
| K221658 | Non-variola Orthopoxvirus Real-time PCR Primer and Probe Set | PBK | 2022-06-10 | 2 |
18 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN070001 | De Novo | Non-Variola Orthopoxvirus Real-Time Pcr Primer And Probe Set | 2018-09-21 |
| DEN130005 | De Novo | Organophosphate Test System | 2013-08-08 |
| DEN120012 | De Novo | Dengue Nucleic Acid Amplification Assay (Naat) | 2012-05-24 |
| DEN060008 | De Novo | Nucleic Acid Amplification, Novel Influenza A Virus, A/H5 (Asian Lineage) Rna | 2006-02-03 |
| P820077 | PMA | AFP MID-PREGNANCY REFERENCE PREPARATION | 1984-11-30 |
Recalls
1 product recalls in 1 recall events; 1 initiated in the last five years. Most recent: 2024-04-26.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Centers For Disease Control and Prevention (CDC) (5 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Centers for Disease Control and Prevention?
FDA lists 28 510(k) clearances under the applicant name “Centers for Disease Control and Prevention” (first 1981, latest 2026), plus 1 PMA and 4 De Novo decisions, across 13 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Centers for Disease Control and Prevention?
The median time from FDA receipt to decision across 510(k)s cleared under the name Centers for Disease Control and Prevention is 36 days. Since 2017: 30 days, versus 84 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Centers for Disease Control and Prevention?
The most frequent FDA product codes under this applicant name are OZE (Influenza A And Influenza B Multiplex Nucleic Acid Assay, 10); PBK (Non-Variola Orthopoxvirus Real-Time Pcr Primer And Probe Set, 5); OQW (2009 H1n1 Influenza Virus (Swine Origin), Nucleic Acid Or Antigen, Detection And Identification, 4).
Next steps
- See all 28 Centers for Disease Control and Prevention clearances with predicates and recalls
- Run predicate analysis for product code OZE, Centers for Disease Control and Prevention's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.